Fritillaria (Fritillaria cirrhosa)

Fritillaria cirrhosa contains alkaloids like peimine and peiminine that modulate STAT1/STAT4 signaling pathways and suppress NF-κB activation. These mechanisms contribute to potential anti-cancer and anti-inflammatory effects in preclinical studies.

Origin & History

Fritillaria cirrhosa, known as Chuan Beimu in Chinese, is a perennial herb native to high-altitude Himalayan regions of China, India, and Nepal, where its bulbs are harvested as the primary medicinal part. The dried bulbs contain steroidal alkaloids and are processed into aqueous extracts or total alkaloid fractions for therapeutic use.

Historical & Cultural Context

In Traditional Chinese Medicine, Fritillariae Cirrhosae Bulbus (Chuan Beimu) has been used for centuries to treat respiratory conditions including cough, phlegm, and lung inflammation. It has served as both a standalone respiratory medicine and as an adjuvant in lung cancer treatment within TCM practice.

Health Benefits

• May inhibit lung cancer cell growth through STAT1/STAT4 pathway activation (preliminary evidence from cell and animal studies)
• Shows potential anti-inflammatory effects by suppressing NF-κB and reducing inflammatory cytokines (animal models only)
• Demonstrates possible respiratory support through traditional antitussive and expectorant properties (traditional use, limited modern evidence)
• Could enhance chemotherapy effectiveness in lung cancer from 70% to 95% (clinical practice reports, not controlled trials)
• May reduce viral inflammation and cytokine storm via STAT/NF-κB/MAPK pathways (preclinical mouse studies)

How It Works

Fritillaria cirrhosa's primary alkaloids peimine and peiminine activate STAT1/STAT4 transcription factors, which regulate immune responses and cell cycle control. The herb also suppresses NF-κB nuclear translocation, reducing production of inflammatory cytokines like TNF-α and IL-6. These dual pathways provide the molecular basis for its traditional respiratory and anti-inflammatory applications.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on Fritillaria cirrhosa. Current evidence is limited to preclinical studies, including in vitro work on A549 lung cancer cells showing apoptosis induction (PMID: 31669666) and mouse xenograft models demonstrating tumor size reduction through immune modulation.

Clinical Summary

Current evidence for Fritillaria cirrhosa comes primarily from in vitro cell culture studies and animal models, with no large-scale human clinical trials available. Cell studies have shown growth inhibition of lung cancer cell lines at concentrations of 50-200 μg/mL. Animal studies in rats demonstrated reduced airway inflammation markers by 30-45% compared to controls. The lack of human clinical data limits conclusions about therapeutic efficacy and optimal dosing in humans.

Nutritional Profile

Fritillaria cirrhosa (Chuan Bei Mu) is a medicinal bulb with limited conventional nutritional data, but several characterized bioactive constituents. Primary bioactive alkaloids include isosteroidal alkaloids: peimisine (imperialine) at approximately 0.01–0.05% dry weight, peiminine (verticine) at 0.02–0.08% dry weight, and verticinone at trace to 0.03% dry weight — these are considered the principal pharmacologically active compounds. Total alkaloid content typically ranges from 0.05–0.2% of dry bulb weight. Steroidal saponins including fritilloside and hupehenine are present at low concentrations (~0.01–0.03% dry weight). Nucleosides detected include adenosine, uridine, and cytidine at microgram-per-gram levels. Polysaccharides (primarily glucomannans and fructans) constitute approximately 15–25% of dry weight and may contribute to mucosal-soothing properties with moderate bioavailability. Crude protein content is approximately 8–12% dry weight, composed largely of non-essential amino acids; not considered a dietary protein source. Crude fiber content is approximately 6–10% dry weight. Mineral content includes potassium (~800–1200 mg/100g dry weight), calcium (~200–400 mg/100g), magnesium (~80–150 mg/100g), and trace iron and zinc. Starch comprises roughly 30–40% dry weight. Fat content is negligible (<2% dry weight). Bioavailability note: alkaloid absorption is enhanced in aqueous decoctions versus raw powder; peimisine demonstrates reasonable oral bioavailability in rodent models (~20–35%), though human pharmacokinetic data remain scarce. Used in doses of 3–9g in decoction, yielding milligram-range alkaloid exposure per therapeutic dose.

Preparation & Dosage

No clinically studied human dosages are available as all research has been preclinical. Traditional use involves dried bulb preparations, but specific dosing for aqueous extracts or alkaloid fractions has not been established in human studies. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Astragalus, Cordyceps, Reishi, Schisandra, American Ginseng

Safety & Interactions

Fritillaria cirrhosa is generally well-tolerated in traditional use, but comprehensive safety data is limited. The herb may interact with anticoagulant medications due to potential effects on platelet aggregation. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Some individuals may experience mild gastrointestinal upset or allergic reactions to the plant alkaloids.